You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graves Disease

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)

Completed
Has Results
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Placebo
  • Beverly Hills, California
  • +13 more
Jan 31, 2022

Clinical Activity of TAO Using Periocular Images Taken by

Completed
  • Thyroid Eye Disease
  • taking periorbital selfie images using smartphones
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Feb 15, 2023

Comorbidities in Alopecia Areata in Czech Republic

Active, not recruiting
  • Alopecia Areata
  • +26 more
  • Exposure of interest
  • Prague, Czechia
    Teaching Hospital of Royal Vineguards
Oct 30, 2021

Thyroid Eye Disease Trial in Tehran (drug, dietary supplement, other)

Withdrawn
  • Thyroid Eye Disease
  • Tehran, Iran, Islamic Republic of
    Rassoul Akram Hospital
Dec 18, 2021

Thyroid Eye Disease Trial in Tehran (Methylprednisolone + ASTED, Methylprednisolone +Placebo)

Withdrawn
  • Thyroid Eye Disease
  • Methylprednisolone + ASTED
  • Methylprednisolone +Placebo
  • Tehran, Iran, Islamic Republic of
  • +1 more
Dec 18, 2021

AS-OCT of the Cornea in Thyroid Diseases

Enrolling by invitation
  • Thyroid Eye Disease
  • AS-OCT
  • Minya, Egypt
  • +1 more
Feb 14, 2022

Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)

Completed
Has Results
  • Thyroid Eye Disease
  • Teprotumumab
  • Beverly Hills, California
  • +12 more
Dec 9, 2021

Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

Recruiting
  • Thyroid Eye Disease
  • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
  • +2 more
  • Boston, Massachusetts
    Mass Eye and Ear
Feb 8, 2022

Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)

Withdrawn
  • Thyroid Associated Ophthalmopathies
  • Sodium selenate
  • Sugar pill
  • (no location specified)
Aug 12, 2021

Heart Rhythm After Intravenous Methylprednisolone Administration

Completed
  • Graves Disease
  • +5 more
  • Intravenous Methylprednisolone
  • (no location specified)
May 13, 2020

Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease Trial in United States (TEPEZZA, Placebo)

Active, not recruiting
  • Thyroid Eye Disease
  • Chronic (Inactive) Thyroid Eye Disease
  • TEPEZZA
  • Placebo
  • Beverly Hills, California
  • +11 more
Nov 4, 2022

Thyroid Eye Disease Trial in Los Angeles (Hyaluronic Acid Gel injection, Saline injection)

Terminated
  • Thyroid Eye Disease
  • Hyaluronic Acid Gel injection
  • Saline injection
  • Los Angeles, California
  • +1 more
Sep 27, 2021

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Completed
  • SCAD
  • +28 more
    • Rochester, Minnesota
      Mayo Clinic
    Nov 20, 2020

    Thyroid Eye Disease Trial (peri-levator betamethasone injection, peri-levator triamcinolone injection, peri-levator and

    Not yet recruiting
    • Thyroid Eye Disease
    • peri-levator betamethasone injection
    • +3 more
    • (no location specified)
    Jul 15, 2021

    Thyroid Ophthalmopathy Trial in Shanghai (HBM9161 680 mg qw by q2w from week 13, Placebo, HBM9161 680 mg qw by q2w from week 7)

    Recruiting
    • Thyroid Ophthalmopathy
    • HBM9161 680 mg qw by q2w from week 13
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, Shanghai Jiaotong University S
    Feb 22, 2022

    Graves Disease Trial (1a-D3, Placebos)

    Completed
    Has Results
    • Graves Disease
    • (no location specified)
    Feb 21, 2020

    High Dose Prednisolone Pharmacokinetics in Acute and Chronic

    Not yet recruiting
    • Thyroid Eye Disease
    • +4 more
    • No intervention - prednisolone is taken as part if routine clinical care.
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Aug 11, 2021

    Thyroid Cancer, Thyroid Goiter, Graves Disease Trial in Toronto (Indocyanine Green)

    Completed
    • Thyroid Cancer
    • +2 more
    • Indocyanine Green
    • Toronto, Ontario, Canada
      University Health Network
    Mar 26, 2020

    Graves Ophthalmopathy Trial in Newcastle upon Tyne (Otelixizumab - low dose, Otelixizumab - medium low dose, Otelixizumab -

    Terminated
    Has Results
    • Graves Ophthalmopathy
    • Otelixizumab - low dose
    • +5 more
    • Newcastle upon Tyne, United Kingdom
      GSK Investigational Site
    Oct 8, 2020

    Thyroid Eye Disease Trial in United States (VRDN-001, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Beverly Hills, California
    • +16 more
    Aug 11, 2022

    Thyroid Eye Disease Trial in Worldwide (Teprotumumab, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Los Angeles, California
    • +28 more
    Jan 19, 2023

    Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

    Recruiting
    • Graves Ophthalmopathy
    • Hsinchu, Taiwan
    • +1 more
    Dec 1, 2022

    Graves Ophthalmopathy Trial in Sofia (Orbital radiotherapy)

    Completed
    • Graves Ophthalmopathy
    • Orbital radiotherapy
    • Sofia, Bulgaria
      University Hospital of Endocrinology
    Mar 7, 2023

    Graves' Disease Trial in Rochester (Levothyroxine, Placebo)

    Completed
    Has Results
    • Graves' Disease
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 11, 2019

    Graves' Disease Trial in Denmark (Cholecalciferol, Placebo)

    Unknown status
    • Graves' Disease
    • Cholecalciferol
    • Placebo
    • Aarhus C, Denmark
    • +7 more
    Oct 21, 2019